Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Carfilzomib Enhances Natural Killer Cell-Mediated Lysis of Myeloma Linked with Decreasing Expression of HLA Class I

Jumei Shi, MD, PhD, Guang Yang, Yuanyuan Kong, Minjie Gao, Yi Tao, Yiwen Zhang, Xiaosong Wu

Blood (2015) 126 (23): 1854.

https://doi.org/10.1182/blood.V126.23.1854.1854

Published: 2015

Journal Articles

Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma

Blood (2014) 124 (21): 1663.

https://doi.org/10.1182/blood.V124.21.1663.1663

Published: 2014

Journal Articles

High Trip13 and Low P31 Comet Cause Drug Resistance and Poor Prognosis In Multiple Myeloma

Yi Tao, MD&PhD, Zhimin Gu, PhD, Ye Yang, PhD, Hongwei Xu, DDS, Xiaojing Hu, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD, Jumei Shi, MD, PhD

Blood (2013) 122 (21): 3820.

https://doi.org/10.1182/blood.V122.21.3820.3820

Published: 2013

Journal Articles

Valproic Acid Upregulates NKG2D Ligand Expression and Potentially Enhances Natural Killer Cell–mediated Cytolysis of Myeloma

Jumei Shi, MD, PhD, Yi Tao, Xiaosong Wu, Xiaojing Hu, Yang Shao, Jun Hou

Blood (2011) 118 (21): 5061.

https://doi.org/10.1182/blood.V118.21.5061.5061

Published: 2011

Journal Articles

TRAIL as the ATO-Target Gene Uniquely Activated In the Hyperdiploid Subtype of Myeloma with Prognostic Relevance, Resulting In Better Prognosis

Jumei Shi, MD, PhD, Jun Hou, Yi Tao, Xiuqin Meng, Ying Han, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD

Blood (2010) 116 (21): 1904.

https://doi.org/10.1182/blood.V116.21.1904.1904

Published: 2010

Journal Articles

Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo .

Tarun K. Garg, PhD, Susann Szmania, BS, Paul Malbrough, BS, Charles Ekworomadu, MS, Katie Stone, BS, Amberly Moreno-Bost, BS, Emily Woods, BS, Jumei Shi, MD, PhD, Shmuel Yaccoby, PhD, John D Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Dario Campana, MD, PhD, Frits van Rhee, MD, PhD

Blood (2009) 114 (22): 953.

https://doi.org/10.1182/blood.V114.22.953.953

Published: 2009

Journal Articles

Arsenic Trioxide-Mediated Growth Inhibition of Myeloma Cells Is Associated with An Extrinsic Signaling Pathway Involved in Caspase 3 and Caspase 8.

Jumei Shi, MD., PhD, Yi Wu, Siqing Wang, MD, MS, Xiuqin Meng, MD., Rong Wei, MD., Xiaojing Hu, MD., PhD, Maurizio Zangari, MD, Guido J. Tricot, MD., PhD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 4899.

https://doi.org/10.1182/blood.V114.22.4899.4899

Published: 2009

Journal Articles

Ex Vivo Activated Natural Killer (NK) Cells from Myeloma Patients Kill Autologous Myeloma and Killing Is Enhanced by Elotuzumab

Tarun K. Garg, PhD, Susann Szmania, BS, Jumei Shi, MD, PhD, Katie Stone, BS, Amberly Moreno-Bost, BS, Paul Malbrough, BS, Dario Campana, MD., PhD, Bart Barlogie, MD, PhD, Daniel Afar, PhD, Frits van Rhee, MD, PhD

Blood (2008) 112 (11): 3666.

https://doi.org/10.1182/blood.V112.11.3666.3666

Published: 2008

Journal Articles

Activation and Expansion of Natural Killer (NK) Cells with Potent Cytotoxicity for Multiple Myeloma

Jumei Shi, MD, PhD, Susann Szmania, BS, Guido Tricot, MD, PhD, Tarun K. Garg, PhD, Priyangi A Malaviarachchi, BS, Amberly Moreno-Bost, BS, Katie Stone, BS, Fenghuang Zhan, MD, PhD, Dario Campana, MD, PhD, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Frits van Rhee, MD, PhD

Blood (2008) 112 (11): 2758.

https://doi.org/10.1182/blood.V112.11.2758.2758

Published: 2008

Journal Articles

Recognition of Myeloma by MAGE-A3 Specific Cytotoxic T Lymphocytes Induced by Treatment with Azacitidine and MGCD0103

Amberly Moreno-Bost, BS, Susann Szmania, BS, Katie Stone, BS, Jumei Shi, MD, PhD, Tarun K. Garg, PhD, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Hugh Grant Prentice, MD, Frits van Rhee, MD, PhD

Blood (2008) 112 (11): 3674.

https://doi.org/10.1182/blood.V112.11.3674.3674

Published: 2008

Journal Articles

A Novel Mechanism of Action of Bortezomib: Proteasome Inhibition Down-Regulates HLA-Class I on Myeloma and Enhances NK Cell-Mediated Lysis.

Jumei Shi, MD, PhD, Guido J. Tricot, MD, PhD, Priyangi A. Malaviarachchi, Tarun K. Garg, PhD, Susann M. Szmania, Arend Mulder, PhD, John D. Shaughnessy, PhD, Bart Barlogie, MD, PhD, Frits van Rhee, MD, PhD

Blood (2007) 110 (11): 1525.

https://doi.org/10.1182/blood.V110.11.1525.1525

Published: 2007

Journal Articles

Bortezomib Down-Regulates HLA Class I and Enhances Natural Killer Cell Mediated Lysis of Myeloma.

Jumei Shi, MD, PhD, Tarun K. Garg, PhD, Rachel E. Kellum, BS, Susann M. Szmania, BS, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD

Blood (2006) 108 (11): 3498.

https://doi.org/10.1182/blood.V108.11.3498.3498

Published: 2006

Journal Articles

Stimulation with K562 Cells Transfected with 4-1BBL and IL-15 Expands and Activates Natural Killer (NK) Cells with Specific Cytotoxicity for Multiple Myeloma (MM).

Jumei Shi, MD, PhD, Guido Tricot, MD, PhD, Susann Szmania, BS, Cristyn Camet, BS, Nancy Rosen, BS, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Dario Campana, MD, PhD, Frits van Rhee, MD, PhD

Blood (2005) 106 (11): 3392.

https://doi.org/10.1182/blood.V106.11.3392.3392

Published: 2005

Journal Articles

KIR-LIGAND Mismatched Natural Killer Cells Effectively Kill Primary Myeloma and Myeloma Cell Lines.

Frits van Rhee, MD, PhD, Susann M. Szmania, BS, JuMei Shi, MD, PhD, Michele Cottler-Fox, MD, Justin W. Dyniewski, Guido J. Tricot, MD, PhD

Blood (2004) 104 (11): 2449.

https://doi.org/10.1182/blood.V104.11.2449.2449

Published: 2004

Journal Articles

Soluble and Membrane Bound MICA in Myeloma Do Not Adversely Effect Regulation of Natural Killer Cell Function Via NKG2D..

Jumei Shi, MD, PhD, Susann Szmania, BS, Fenghuang Zhan, PhD, John Shaughnessy, PhD, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD

Blood (2004) 104 (11): 2462.

https://doi.org/10.1182/blood.V104.11.2462.2462

Published: 2004

NARROW

Carfilzomib Enhances Natural Killer Cell-Mediated Lysis of Myeloma Linked with Decreasing Expression of HLA Class I

Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma

High Trip13 and Low P31 Comet Cause Drug Resistance and Poor Prognosis In Multiple Myeloma

Valproic Acid Upregulates NKG2D Ligand Expression and Potentially Enhances Natural Killer Cell–mediated Cytolysis of Myeloma

TRAIL as the ATO-Target Gene Uniquely Activated In the Hyperdiploid Subtype of Myeloma with Prognostic Relevance, Resulting In Better Prognosis

Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo .

Arsenic Trioxide-Mediated Growth Inhibition of Myeloma Cells Is Associated with An Extrinsic Signaling Pathway Involved in Caspase 3 and Caspase 8.

Ex Vivo Activated Natural Killer (NK) Cells from Myeloma Patients Kill Autologous Myeloma and Killing Is Enhanced by Elotuzumab

Activation and Expansion of Natural Killer (NK) Cells with Potent Cytotoxicity for Multiple Myeloma

Recognition of Myeloma by MAGE-A3 Specific Cytotoxic T Lymphocytes Induced by Treatment with Azacitidine and MGCD0103

A Novel Mechanism of Action of Bortezomib: Proteasome Inhibition Down-Regulates HLA-Class I on Myeloma and Enhances NK Cell-Mediated Lysis.

Bortezomib Down-Regulates HLA Class I and Enhances Natural Killer Cell Mediated Lysis of Myeloma.

Stimulation with K562 Cells Transfected with 4-1BBL and IL-15 Expands and Activates Natural Killer (NK) Cells with Specific Cytotoxicity for Multiple Myeloma (MM).

KIR-LIGAND Mismatched Natural Killer Cells Effectively Kill Primary Myeloma and Myeloma Cell Lines.

Soluble and Membrane Bound MICA in Myeloma Do Not Adversely Effect Regulation of Natural Killer Cell Function Via NKG2D..

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only